Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Moderate-to-Severe Plaque Psoriasis: The Chinese Healthcare System Perspective.

Jinsui Zhang,Zemin Xia,Wanjie Guo,Xiaoxiao Ren,Fang Liu,Gargi Ratnaparkhi,Amit Pagada,Subhashini Subramanian,Min Hu,Wen Chen

Dermatology and therapy（2023）

引用 0|浏览5

暂无评分

摘要

Secukinumab is the most cost-effective treatment option for patients with moderate-to-severe psoriasis compared with other commonly used biologics from the Chinese healthcare system perspective.

查看译文

关键词

Cost-effectiveness, Psoriasis, Secukinumab, Biologics, Incremental cost-effectiveness ratio, Quality-adjusted life year, China

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要